Skip to main content
Premium Trial:

Request an Annual Quote

Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion

NEW YORK — Quadrant Biosciences said on Monday that it has received a $2.3 million grant from the National Institutes of Health to develop its saliva-based microRNA diagnostic test for concussions in children and adolescents.

Syracuse, New York-based Quadrant has been working with researchers from Penn State University and SUNY Upstate Medical University on saliva-based biomarkers of various neurological conditions. In 2018, they published data linking saliva concentrations of multiple miRNAs with concussion duration and symptoms in children.

With the newly awarded Fast-Track Phase I/II Small Business Technology Transfer grant, Quadrant aims to develop a rapid method for quantifying these biomarkers for potential point-of-care use. It also plans to validate a diagnostic algorithm designed to distinguish mild traumatic brain injury (mTBI) from medical conditions with overlapping symptoms, such as chronic headaches and exercise-related fatigue.

The research will be conducted in a study of 2,500 adolescents and young adults with either a formal diagnosis of an mTBI or an overlapping medical condition, in collaboration with SUNY Upstate, SUNY Buffalo, Arkansas Children's, Children's Hospital of Michigan, and Penn State Medical Centers.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.